Legal & General Group Plc Purchases Shares of 351,867 Sotera Health Company $SHC

Legal & General Group Plc acquired a new position in shares of Sotera Health Company (NASDAQ:SHC) in the second quarter, Holdings Channel.com reports. The institutional investor acquired 351,867 shares of the company’s stock, valued at approximately $6,246,000.

Other institutional investors and hedge funds have also recently modified their holdings of the company. BlackRock Inc. bought a new position in shares of Sotera Health in the second quarter valued at approximately $428,635,000. Sculptor Capital LP grew its holdings in Sotera Health by 57.4% during the fourth quarter. Sculptor Capital LP now owns 21,000,000 shares of the company’s stock worth $370,440,000 after buying an additional 7,658,200 shares in the last quarter. Two Seas Capital LP purchased a new stake in Sotera Health in the 2nd quarter valued at $103,590,000. Sachem Head Capital Management LP raised its position in Sotera Health by 47.2% in the 4th quarter. Sachem Head Capital Management LP now owns 11,645,000 shares of the company’s stock valued at $205,418,000 after buying an additional 3,735,000 shares during the last quarter. Finally, Vanguard Group Inc. lifted its stake in Sotera Health by 16.7% during the 4th quarter. Vanguard Group Inc. now owns 19,228,375 shares of the company’s stock valued at $339,189,000 after acquiring an additional 2,756,583 shares in the last quarter. 91.03% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Sotera Health

In other news, Chairman Michael B. Jr. Petras sold 850,000 shares of the business’s stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $18.50, for a total value of $15,725,000.00. Following the sale, the chairman owned 3,969,393 shares of the company’s stock, valued at $73,433,770.50. The trade was a 17.64% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Michael P. Rutz sold 150,000 shares of the business’s stock in a transaction that occurred on Friday, August 7th. The shares were sold at an average price of $18.84, for a total transaction of $2,826,000.00. Following the completion of the sale, the insider directly owned 334,279 shares in the company, valued at approximately $6,297,816.36. This trade represents a 30.97% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 1,294,515 shares of company stock valued at $23,999,528 in the last quarter. Company insiders own 15.36% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have issued reports on the stock. Barclays lifted their price objective on shares of Sotera Health from $19.00 to $22.00 and gave the stock an “overweight” rating in a report on Friday, August 7th. Weiss Ratings upgraded shares of Sotera Health from a “hold (c)” rating to a “hold (c+)” rating in a report on Tuesday, August 11th. The Goldman Sachs Group started coverage on shares of Sotera Health in a research report on Friday, June 5th. They set a “buy” rating and a $20.00 price target on the stock. Citigroup boosted their price target on shares of Sotera Health from $23.00 to $25.00 and gave the stock a “buy” rating in a report on Friday, August 7th. Finally, Wall Street Zen upgraded shares of Sotera Health from a “buy” rating to a “strong-buy” rating in a research note on Saturday, August 29th. Eight research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat.com, Sotera Health presently has an average rating of “Moderate Buy” and an average target price of $21.50.

Sotera Health Stock Performance

NASDAQ:SHC opened at $18.96 on Thursday. The company has a market capitalization of $5.41 billion, a P/E ratio of 33.26 and a beta of 1.77. The business has a fifty day simple moving average of $18.28 and a two-hundred day simple moving average of $16.44. The company has a debt-to-equity ratio of 3.33, a current ratio of 2.80 and a quick ratio of 2.55. Sotera Health Company has a 1 year low of $13.09 and a 1 year high of $19.85.

Sotera Health (NASDAQ:SHC) last issued its quarterly earnings results on Thursday, August 6th. The company reported $0.26 EPS for the quarter, beating analysts’ consensus estimates of $0.24 by $0.02. The firm had revenue of $321.38 million for the quarter, compared to analysts’ expectations of $309.70 million. Sotera Health had a return on equity of 40.12% and a net margin of 13.44%.The business’s revenue for the quarter was up 9.2% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.20 EPS. Sotera Health has set its FY 2026 guidance at 0.950-1.010 EPS. On average, analysts expect that Sotera Health Company will post 0.86 earnings per share for the current year.

Sotera Health Profile

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.